TransThera Sciences (Nanjing), Inc. (HKG:2617)
68.60
-1.00 (-1.44%)
Apr 17, 2026, 3:45 PM HKT
HKG:2617 Statistics
Total Valuation
HKG:2617 has a market cap or net worth of HKD 27.77 billion. The enterprise value is 27.23 billion.
| Market Cap | 27.77B |
| Enterprise Value | 27.23B |
Important Dates
The last earnings date was Tuesday, March 31, 2026.
| Earnings Date | Mar 31, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2617 has 399.00 million shares outstanding. The number of shares has increased by 2.11% in one year.
| Current Share Class | 303.77M |
| Shares Outstanding | 399.00M |
| Shares Change (YoY) | +2.11% |
| Shares Change (QoQ) | +3.90% |
| Owned by Insiders (%) | 11.99% |
| Owned by Institutions (%) | 28.68% |
| Float | 120.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 59.93 |
| P/TBV Ratio | 60.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -82.67 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.87, with a Debt / Equity ratio of 0.00.
| Current Ratio | 3.87 |
| Quick Ratio | 3.80 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2,492.05 |
Financial Efficiency
Return on equity (ROE) is -62.88% and return on invested capital (ROIC) is -39.78%.
| Return on Equity (ROE) | -62.88% |
| Return on Assets (ROA) | -32.06% |
| Return on Invested Capital (ROIC) | -39.78% |
| Return on Capital Employed (ROCE) | -72.42% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -2.72M |
| Employee Count | 121 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 71.27 |
| 200-Day Moving Average | 105.49 |
| Relative Strength Index (RSI) | 46.72 |
| Average Volume (20 Days) | 1,405,594 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -335.55M |
| Pretax Income | -329.35M |
| Net Income | -329.35M |
| EBITDA | -332.31M |
| EBIT | -335.55M |
| Earnings Per Share (EPS) | -0.85 |
Balance Sheet
The company has 544.60 million in cash and 1.83 million in debt, with a net cash position of 542.77 million or 1.36 per share.
| Cash & Cash Equivalents | 544.60M |
| Total Debt | 1.83M |
| Net Cash | 542.77M |
| Net Cash Per Share | 1.36 |
| Equity (Book Value) | 463.35M |
| Book Value Per Share | 1.17 |
| Working Capital | 413.21M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 3.35M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HKG:2617 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.11% |
| Shareholder Yield | -2.11% |
| Earnings Yield | -1.19% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |